Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2008

01-01-2008 | Original Paper

Development of Functional Diarrhea, Constipation, Irritable Bowel Syndrome, and Dyspepsia During and After Traveling Outside the USA

Authors: Ashok K. Tuteja, Nicholas J. Talley, Stephanie S. Gelman, Stephen C. Adler, Clinton Thompson, Keith Tolman, DeVon C. Hale

Published in: Digestive Diseases and Sciences | Issue 1/2008

Login to get access

Abstract

Background   Persistent gastrointestinal (GI) symptoms after travel abroad may be common. It remains unclear how often subjects who developed new GI symptoms while abroad have persistent symptoms on return. The objective of this retrospective study was to evaluate the prevalence of persistent GI symptoms in a healthy cohort of travelers. Methods   One hundred and eight consecutive patients, mostly returned missionaries, attending the University of Utah International Travel Clinic for any reason (but mostly GI symptoms) had data recorded about their bowel habits before, during, and after travel abroad. All subjects had standard hematological, biochemical, and microbiological tests to exclude known causes of their symptoms. Endoscopic procedures were performed when considered necessary by the treating physician. Diarrhea, constipation, irritable bowel syndrome (IBS), bloating, and dyspepsia were defined according to the Rome II Criteria. Results   Eighty three (82% men and 18% women, median age 21 years) completed the survey with 68 subjects completing the questionnaire about bowel habits before and during travel. Among the respondents, 55 (82.1%) did not have any symptoms before travel. During travel, 41 (63%) developed new onset diarrhea; 6 (9%) developed constipation; 16 (24%) IBS, 29 (45%) bloating; and 11 (16%) dyspepsia. Of those who developed symptoms during travel, 27 (68%) had persistent diarrhea, 3 (50%) had persistent constipation, 10 (63%) had persistent IBS, 12 (43%) had persistent bloating and 8 (73%) had persistent dyspepsia. The presence of bowel symptoms during and after travel was not associated with age, gender, travel destination, or duration of travel. Conclusions: This study suggests that new onset of diarrhea, IBS, constipation, and dyspepsia are common among subjects traveling abroad. Gastrointestinal symptoms that develop during travel abroad usually persist on return.
Literature
1.
go back to reference Steffen R, Rickenbach M, Wilhelm U, Helminger A, Schar M (1987) Health problems after travel to developing countries. J Infect Dis 156(1):84–91PubMed Steffen R, Rickenbach M, Wilhelm U, Helminger A, Schar M (1987) Health problems after travel to developing countries. J Infect Dis 156(1):84–91PubMed
2.
go back to reference Ryan ET, Wilson ME, Kain KC (2002) Illness after international travel. N Engl J Med 347(7):505–516PubMedCrossRef Ryan ET, Wilson ME, Kain KC (2002) Illness after international travel. N Engl J Med 347(7):505–516PubMedCrossRef
3.
go back to reference Taylor DN, Connor BA, Shlim DR (1999) Chronic diarrhea in the returned traveler. Med Clin North Am 83(4):1033–1052 viiPubMed Taylor DN, Connor BA, Shlim DR (1999) Chronic diarrhea in the returned traveler. Med Clin North Am 83(4):1033–1052 viiPubMed
4.
go back to reference DuPont HL, Capsuto EG (1996) Persistent diarrhea in travelers. Clin Infect Dis 22(1):124–128PubMed DuPont HL, Capsuto EG (1996) Persistent diarrhea in travelers. Clin Infect Dis 22(1):124–128PubMed
5.
go back to reference Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL (2004) Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 99(9):1774–1778PubMedCrossRef Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL (2004) Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 99(9):1774–1778PubMedCrossRef
6.
go back to reference Ilnyckyj A, Balachandra B, Elliott L, Choudhri S, Duerksen DR (2003) Post-traveler’s diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol 98(3):596–599PubMedCrossRef Ilnyckyj A, Balachandra B, Elliott L, Choudhri S, Duerksen DR (2003) Post-traveler’s diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol 98(3):596–599PubMedCrossRef
7.
go back to reference Mearin F, Perez-Oliveras M, Perello A et al (2005) Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 129(1):98–104PubMedCrossRef Mearin F, Perez-Oliveras M, Perello A et al (2005) Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 129(1):98–104PubMedCrossRef
8.
go back to reference Talley NJ, Phillips SF, Melton J III, Wiltgen C, Zinsmeister AR (1989) A patient questionnaire to identify bowel disease. Ann Intern Med 111(8):671–674PubMed Talley NJ, Phillips SF, Melton J III, Wiltgen C, Zinsmeister AR (1989) A patient questionnaire to identify bowel disease. Ann Intern Med 111(8):671–674PubMed
9.
go back to reference Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ (1995) Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med 25(4):302–308PubMed Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ (1995) Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med 25(4):302–308PubMed
10.
go back to reference Thompson WG, Longstreth G, Drossman DA, Heaton K, Irvine EJ, Muller-Lissner S (2000) Functional bowel disorders and functional abdominal pain. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE (eds) Rome II: the functional gastrointestinal disorders, 2nd edn. Degnon Associates, McLean, VA, pp 351–432 Thompson WG, Longstreth G, Drossman DA, Heaton K, Irvine EJ, Muller-Lissner S (2000) Functional bowel disorders and functional abdominal pain. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE (eds) Rome II: the functional gastrointestinal disorders, 2nd edn. Degnon Associates, McLean, VA, pp 351–432
11.
go back to reference Sostek MB, Jackson S, Linevsky JK, Schimmel EM, Fincke BG (1996) High prevalence of chronic gastrointestinal symptoms in a National Guard Unit of Persian Gulf veterans. Am J Gastroenterol 91(12):2494–2497PubMed Sostek MB, Jackson S, Linevsky JK, Schimmel EM, Fincke BG (1996) High prevalence of chronic gastrointestinal symptoms in a National Guard Unit of Persian Gulf veterans. Am J Gastroenterol 91(12):2494–2497PubMed
12.
go back to reference Collins SM (2002) A case for an immunological basis for irritable bowel syndrome. Gastroenterology 122(7):2078–2080PubMedCrossRef Collins SM (2002) A case for an immunological basis for irritable bowel syndrome. Gastroenterology 122(7):2078–2080PubMedCrossRef
13.
14.
go back to reference Collins SM, Piche T, Rampal P (2001) The putative role of inflammation in the irritable bowel syndrome. Gut 49(6):743–745PubMedCrossRef Collins SM, Piche T, Rampal P (2001) The putative role of inflammation in the irritable bowel syndrome. Gut 49(6):743–745PubMedCrossRef
15.
go back to reference Anderzen I, Arnetz BB (1999) Psychophysiological reactions to international adjustment. Results from a controlled, longitudinal study. Psychother Psychosom 68(2):67–75PubMedCrossRef Anderzen I, Arnetz BB (1999) Psychophysiological reactions to international adjustment. Results from a controlled, longitudinal study. Psychother Psychosom 68(2):67–75PubMedCrossRef
16.
go back to reference Mayer EA, Gebhart GF (1994) Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107(1):271–293PubMed Mayer EA, Gebhart GF (1994) Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107(1):271–293PubMed
Metadata
Title
Development of Functional Diarrhea, Constipation, Irritable Bowel Syndrome, and Dyspepsia During and After Traveling Outside the USA
Authors
Ashok K. Tuteja
Nicholas J. Talley
Stephanie S. Gelman
Stephen C. Adler
Clinton Thompson
Keith Tolman
DeVon C. Hale
Publication date
01-01-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9853-x

Other articles of this Issue 1/2008

Digestive Diseases and Sciences 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine